This non-interventional study of real-life clinical practice strategies for long-term relapse control in patients with psoriasis vulgaris is planned to enroll 650 adult patients from 60-100 Russian dermatology sites and follow the patients for up to 52 weeks. The study will map actual strategies and focus on patients' and dermatologists' experience with the different topicals used, including unspecified products with and without active drugs.
Study Type
OBSERVATIONAL
Enrollment
764
Any treatment strategy used to prevent relapse of psoriasis symptoms
The State Autonomous Foundation of Public Health "Republic Clinical Dermatovenereological Dispensary" of the Republic of Tatarstan
Kazan', Tatarstan Republic, Russia
Time of relapse
Length of relapse free period after start of maintenance strategy
Time frame: Up to 52 weeks
Dermatology Life Quality Index
Standard QoL measure within dermatology
Time frame: Up to 52 weeks
PGA (physician's global assessment of symptoms)
5-point verbal rating scale
Time frame: Up to 52 weeks
PsGA (patient's global assessment of symptoms)
5-point verbal rating scale
Time frame: Up to 52 weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.